These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28207495)

  • 21. Risk factors for cardiovascular disease in rheumatoid arthritis.
    Gabriel SE; Crowson CS
    Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.
    Myasoedova E; Crowson CS; Kremers HM; Roger VL; Fitz-Gibbon PD; Therneau TM; Gabriel SE
    Ann Rheum Dis; 2011 Mar; 70(3):482-7. PubMed ID: 21216812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.
    Tournadre A; Pereira B; Dubost JJ; Rincheval N; Rat AC; Combe B; Soubrier M
    Clin Exp Rheumatol; 2017; 35(2):296-302. PubMed ID: 28079508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
    Zhang J; Xie F; Yun H; Chen L; Muntner P; Levitan EB; Safford MM; Kent ST; Osterman MT; Lewis JD; Saag K; Singh JA; Curtis JR
    Ann Rheum Dis; 2016 Oct; 75(10):1813-8. PubMed ID: 26792814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular diseases in rheumatoid arthritis].
    Nakajima A
    Nihon Rinsho; 2016 Jun; 74(6):1012-6. PubMed ID: 27311194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.
    Giles JT; Post W; Blumenthal RS; Bathon JM
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.
    Navarro-Millán I; Goyal P; Safford MM
    Rheumatology (Oxford); 2019 Jun; 58(6):933-934. PubMed ID: 30272226
    [No Abstract]   [Full Text] [Related]  

  • 29. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.
    Toussirot É
    Expert Opin Drug Saf; 2015 Apr; 14(4):525-32. PubMed ID: 25599626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors.
    Toms TE; Symmons DP; Kitas GD
    Curr Vasc Pharmacol; 2010 May; 8(3):301-26. PubMed ID: 19758115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis.
    Cho SK; Kim D; Won S; Lee J; Park B; Jang EJ; Bae SC; Sung YK
    Semin Arthritis Rheum; 2018 Feb; 47(4):501-506. PubMed ID: 28863826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
    Drakopoulou M; Soulaidopoulos S; Oikonomou G; Tousoulis D; Toutouzas K
    Curr Vasc Pharmacol; 2020; 18(5):488-506. PubMed ID: 32056527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy.
    Feehan LM; Li LL; McKay HA
    BMC Musculoskelet Disord; 2017 Dec; 18(1):521. PubMed ID: 29228959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex and Management of Rheumatoid Arthritis.
    Favalli EG; Biggioggero M; Crotti C; Becciolini A; Raimondo MG; Meroni PL
    Clin Rev Allergy Immunol; 2019 Jun; 56(3):333-345. PubMed ID: 29372537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?
    Pieringer H; Pichler M; Pohanka E; Hoppe UC
    Curr Pharm Des; 2014; 20(4):486-95. PubMed ID: 23565635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
    Nandi P; Kingsley GH; Scott DL
    Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.